SCOTT D SANDELL Transaction History

Date Transaction Value Shares Traded Form
Jun 28 2021
BUY
Open market or private purchase
$19,950,000 $19.0 p/Share
1,050,000
Jun 28 2021
BUY
Conversion of derivative security
-
6,642,298

Also insider at

EAR
Eargo, Inc. Healthcare
NET
Cloudflare, Inc. Technology
SPT
Sprout Social, Inc. Technology
RGLS
Regulus Therapeutics Inc. Healthcare
BE
Bloom Energy Corp Industrials
MRKR
Marker Therapeutics, Inc. Healthcare
COUR
Coursera, Inc. Consumer Defensive
DM
Desktop Metal, Inc. Technology
BHG
Bright Health Group Inc. Healthcare
HOOD
Robinhood Markets, Inc. Technology
TRVI
Trevi Therapeutics, Inc. Healthcare
ARDX
ARDELYX, INC. Healthcare
MTCR
Metacrine, Inc. Healthcare
GNCA
GENOCEA BIOSCIENCES, INC. Healthcare
AVEO
AVEO PHARMACEUTICALS, INC. Healthcare
IONQ
IonQ, Inc. Technology
AKUS
Akouos, Inc. Healthcare
ACLX
Arcellx, Inc. Healthcare
GLYC
GLYCOMIMETICS INC Healthcare
MIRM
Mirum Pharmaceuticals, Inc. Healthcare
SVRA
Savara Inc Healthcare
SGMT
Sagimet Biosciences Inc.
FREQ
Frequency Therapeutics, Inc. Healthcare
SDS

Scott D Sandell

> 10% Shareholder
Timonium, MD

Track Institutional and Insider Activities on GLUE

Follow Monte Rosa Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GLUE shares.

Notify only if

Insider Trading

Get notified when an Monte Rosa Therapeutics, Inc. insider buys or sells GLUE shares.

Notify only if

News

Receive news related to Monte Rosa Therapeutics, Inc.

Track Activities on GLUE